{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:17:29Z","timestamp":1790749049987,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutations in the type 1 ryanodine receptor (RyR1), a Ca<jats:sup>2+<\/jats:sup> release channel in skeletal muscle, hyperactivate the channel to cause malignant hyperthermia (MH) and are implicated in severe heat stroke. Dantrolene, the only approved drug for MH, has the disadvantages of having very poor water solubility and long plasma half-life. We show here that an oxolinic acid-derivative RyR1-selective inhibitor, 6,7-(methylenedioxy)-1-octyl-4-quinolone-3-carboxylic acid (Compound 1, Cpd1), effectively prevents and treats MH and heat stroke in several mouse models relevant to MH. Cpd1 reduces resting intracellular Ca<jats:sup>2+<\/jats:sup>, inhibits halothane- and isoflurane-induced Ca<jats:sup>2+<\/jats:sup> release, suppresses caffeine-induced contracture in skeletal muscle, reduces sarcolemmal cation influx, and prevents or reverses the fulminant MH crisis induced by isoflurane anesthesia and rescues animals from heat stroke caused by environmental heat stress. Notably, Cpd1 has great advantages of better water solubility and rapid clearance in vivo over dantrolene. Cpd1 has the potential to be a promising candidate for effective treatment of patients carrying RyR1 mutations.<\/jats:p>","DOI":"10.1038\/s41467-021-24644-1","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T10:24:02Z","timestamp":1626171842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["A novel RyR1-selective inhibitor prevents and rescues sudden death in mouse models of malignant hyperthermia and heat stroke"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4368-4794","authenticated-orcid":false,"given":"Toshiko","family":"Yamazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3992-1889","authenticated-orcid":false,"given":"Takuya","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5005-9698","authenticated-orcid":false,"given":"Nagomi","family":"Kurebayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6165-3716","authenticated-orcid":false,"given":"Satoru","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7155-2150","authenticated-orcid":false,"given":"Takayoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4105-9127","authenticated-orcid":false,"given":"Yukiko U.","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9452-112X","authenticated-orcid":false,"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Iinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Manaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kagechika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1434-8342","authenticated-orcid":false,"given":"Arkady","family":"Uryash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose R.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Diggle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Kakizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5877-949X","authenticated-orcid":false,"given":"Bangzhong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5687-8988","authenticated-orcid":false,"given":"Yui","family":"Ikemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6444-3244","authenticated-orcid":false,"given":"Kazuto","family":"Nunomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsaku","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9515-6574","authenticated-orcid":false,"given":"Takashi","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3845-2980","authenticated-orcid":false,"given":"Takashi","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,13]]},"reference":[{"key":"24644_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.ph.56.030194.002413","volume":"56","author":"G Meissner","year":"1994","unstructured":"Meissner, G. Ryanodine receptor\/Ca2+ release channels and their regulation by endogenous effectors. Annu. Rev. Physiol. 56, 485\u2013508 (1994).","journal-title":"Annu. Rev. Physiol."},{"key":"24644_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3109\/10409239409083482","volume":"29","author":"Y Ogawa","year":"1994","unstructured":"Ogawa, Y. Role of ryanodine receptors. Crit. Rev. Biochem. Mol. Biol. 29, 229\u2013274 (1994).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"24644_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.ph.54.030192.000545","volume":"54","author":"E Rios","year":"1992","unstructured":"Rios, E., Pizarro, G. & Stefani, E. Charge movement and the nature of signal transduction in skeletal muscle excitation-contraction coupling. Annu. Rev. Physiol. 54, 109\u2013133 (1992).","journal-title":"Annu. Rev. Physiol."},{"key":"24644_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.ph.56.030194.002335","volume":"56","author":"MF Schneider","year":"1994","unstructured":"Schneider, M. F. Control of calcium release in functioning skeletal muscle fibers. Annu. Rev. Physiol. 56, 463\u2013484 (1994).","journal-title":"Annu. Rev. Physiol."},{"key":"24644_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1152\/physrev.1977.57.1.71","volume":"57","author":"M Endo","year":"1977","unstructured":"Endo, M. Calcium release from the sarcoplasmic reticulum. Physiol. Rev. 57, 71\u2013108 (1977).","journal-title":"Physiol. Rev."},{"key":"24644_CR6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1152\/physrev.00040.2008","volume":"89","author":"M Endo","year":"2009","unstructured":"Endo, M. Calcium-induced calcium release in skeletal muscle. Physiol. Rev. 89, 1153\u20131176 (2009).","journal-title":"Physiol. Rev."},{"key":"24644_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.pbiomolbio.2010.10.003","volume":"105","author":"T Murayama","year":"2011","unstructured":"Murayama, T. & Kurebayashi, N. Two ryanodine receptor isoforms in nonmammalian vertebrate skeletal muscle: possible roles in excitation-contraction coupling and other processes. Prog. Biophys. Mol. Biol. 105, 134\u2013144 (2011).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"24644_CR8","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/humu.20356","volume":"27","author":"R Robinson","year":"2006","unstructured":"Robinson, R., Carpenter, D., Shaw, M. A., Halsall, J. & Hopkins, P. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum. Mutat. 27, 977\u2013989 (2006).","journal-title":"Hum. Mutat."},{"key":"24644_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/bja\/85.1.118","volume":"85","author":"PM Hopkins","year":"2000","unstructured":"Hopkins, P. M. Malignant hyperthermia: advances in clinical management and diagnosis. Br. J. Anaesth. 85, 118\u2013128 (2000).","journal-title":"Br. J. Anaesth."},{"key":"24644_CR10","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0002-9343(98)00108-9","volume":"104","author":"J Loke","year":"1998","unstructured":"Loke, J. & MacLennan, D. H. Malignant hyperthermia and central core disease: disorders of Ca2+ release channels. Am. J. Med. 104, 470\u2013486 (1998).","journal-title":"Am. J. Med."},{"key":"24644_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1152\/physrev.1996.76.2.537","volume":"76","author":"JR Mickelson","year":"1996","unstructured":"Mickelson, J. R. & Louis, C. F. Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects. Physiol. Rev. 76, 537\u2013592 (1996).","journal-title":"Physiol. Rev."},{"key":"24644_CR12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/cphy.c140017","volume":"5","author":"LR Leon","year":"2015","unstructured":"Leon, L. R. & Bouchama, A. Heat stroke. Compr. Physiol. 5, 611\u2013647 (2015).","journal-title":"Compr. Physiol."},{"key":"24644_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-018-0298-4","volume":"6","author":"T Hifumi","year":"2018","unstructured":"Hifumi, T., Kondo, Y., Shimizu, K. & Miyake, Y. Heat stroke. J. Intensive Care 6, 30 (2018).","journal-title":"J. Intensive Care"},{"key":"24644_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/bja\/88.4.508","volume":"88","author":"M Davis","year":"2002","unstructured":"Davis, M. et al. Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees. Br. J. Anaesth. 88, 508\u2013515 (2002).","journal-title":"Br. J. Anaesth."},{"key":"24644_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/00000542-200101000-00019","volume":"94","author":"F Wappler","year":"2001","unstructured":"Wappler, F. et al. Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis. Anesthesiology 94, 95\u2013100 (2001).","journal-title":"Anesthesiology"},{"key":"24644_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/jama.286.2.168","volume":"286","author":"JR Tobin","year":"2001","unstructured":"Tobin, J. R., Jason, D. R., Challa, V. R., Nelson, T. E. & Sambuughin, N. Malignant hyperthermia and apparent heat stroke. JAMA 286, 168\u2013169 (2001).","journal-title":"JAMA"},{"key":"24644_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00000542-198204000-00005","volume":"56","author":"ME Kolb","year":"1982","unstructured":"Kolb, M. E., Horne, M. L. & Martz, R. Dantrolene in human malignant hyperthermia. Anesthesiology 56, 254\u2013262 (1982).","journal-title":"Anesthesiology"},{"key":"24644_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1113\/jphysiol.1981.sp013591","volume":"311","author":"C Krarup","year":"1981","unstructured":"Krarup, C. The effect of dantrolene on the enhancement and diminution of tension evoked by staircase and by tetanus in rat muscle. J. Physiol. 311, 389\u2013400 (1981).","journal-title":"J. Physiol."},{"key":"24644_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/jm00317a011","volume":"10","author":"HR Snyder Jr.","year":"1967","unstructured":"Snyder, H. R. Jr., Davis, C. S., Bickerton, R. K. & Halliday, R. P. 1-[(5-arylfurfurylidene)amino]hydantoins. A new class of muscle relaxants. J. Med. Chem. 10, 807\u2013810 (1967).","journal-title":"J. Med. Chem."},{"key":"24644_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1021\/bi001502s","volume":"40","author":"K Paul-Pletzer","year":"2001","unstructured":"Paul-Pletzer, K., Palnitkar, S. S., Jimenez, L. S., Morimoto, H. & Parness, J. The skeletal muscle ryanodine receptor identified as a molecular target of [3H]azidodantrolene by photoaffinity labeling. Biochemistry 40, 531\u2013542 (2001).","journal-title":"Biochemistry"},{"key":"24644_CR21","doi-asserted-by":"publisher","first-page":"13810","DOI":"10.1074\/jbc.M006104200","volume":"276","author":"F Zhao","year":"2001","unstructured":"Zhao, F. et al. Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity. J. Biol. Chem. 276, 13810\u201313816 (2001).","journal-title":"J. Biol. Chem."},{"key":"24644_CR22","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","volume":"59","author":"T Krause","year":"2004","unstructured":"Krause, T., Gerbershagen, M. U., Fiege, M., Weisshorn, R. & Wappler, F. Dantrolene: a review of its pharmacology, therapeutic use and new developments. Anaesthesia 59, 364\u2013373 (2004).","journal-title":"Anaesthesia"},{"key":"24644_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00000542-198310000-00002","volume":"59","author":"EH Flewellen","year":"1983","unstructured":"Flewellen, E. H., Nelson, T. E., Jones, W. P., Arens, J. F. & Wagner, D. L. Dantrolene dose response in awake man: implications for management of malignant hyperthermia. Anesthesiology 59, 275\u2013280 (1983).","journal-title":"Anesthesiology"},{"key":"24644_CR24","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1002\/cpph.71","volume":"87","author":"T Murayama","year":"2019","unstructured":"Murayama, T. & Kurebayashi, N. Assays for modulators of ryanodine receptor (RyR)\/Ca(2+) release channel activity for drug discovery for skeletal muscle and heart diseases. Curr. Protoc. Pharm. 87, e71 (2019).","journal-title":"Curr. Protoc. Pharm."},{"key":"24644_CR25","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1124\/mol.117.111468","volume":"94","author":"T Murayama","year":"2018","unstructured":"Murayama, T. et al. Efficient high-throughput screening by endoplasmic reticulum Ca2+ measurement to identify inhibitors of ryanodine receptor Ca2+-release channels. Mol. Pharm. 94, 722\u2013730 (2018).","journal-title":"Mol. Pharm."},{"key":"24644_CR26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.ejmech.2019.06.076","volume":"179","author":"S Mori","year":"2019","unstructured":"Mori, S. et al. Structural development of a type-1 ryanodine receptor (RyR1) Ca2+-release channel inhibitor guided by endoplasmic reticulum Ca2+ assay. Eur. J. Med. Chem. 179, 837\u2013848 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"24644_CR27","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","volume":"104","author":"MC Ibarra","year":"2006","unstructured":"Ibarra, M. C. et al. Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing. Anesthesiology 104, 1146\u20131154 (2006).","journal-title":"Anesthesiology"},{"key":"24644_CR28","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/humu.23072","volume":"37","author":"T Murayama","year":"2016","unstructured":"Murayama, T. et al. Genotype-phenotype correlations of malignant hyperthermia and central core disease mutations in the central region of the RYR1 channel. Hum. Mutat. 37, 1231\u20131241 (2016).","journal-title":"Hum. Mutat."},{"key":"24644_CR29","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1097\/00000542-200612000-00016","volume":"105","author":"T Yang","year":"2006","unstructured":"Yang, T. et al. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Anesthesiology 105, 1164\u20131175 (2006).","journal-title":"Anesthesiology"},{"key":"24644_CR30","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.bja.2018.07.008","volume":"121","author":"JR Lopez","year":"2018","unstructured":"Lopez, J. R., Kaura, V., Diggle, C. P., Hopkins, P. M. & Allen, P. D. Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1. Br. J. Anaesth. 121, 953\u2013961 (2018).","journal-title":"Br. J. Anaesth."},{"key":"24644_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/00000542-199201000-00019","volume":"76","author":"PD Allen","year":"1992","unstructured":"Allen, P. D., Lopez, J. R., Sanchez, V., Ryan, J. F. & Sreter, F. A. EU 4093 decreases intracellular [Ca2+] in skeletal muscle fibers from control and malignant hyperthermia-susceptible swine. Anesthesiology 76, 132\u2013138 (1992).","journal-title":"Anesthesiology"},{"key":"24644_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/mus.880110113","volume":"11","author":"JR Lopez","year":"1988","unstructured":"Lopez, J. R., Allen, P. D., Alamo, L., Jones, D. & Sreter, F. A. Myoplasmic free [Ca2+] during a malignant hyperthermia episode in swine. Muscle Nerve 11, 82\u201388 (1988).","journal-title":"Muscle Nerve"},{"key":"24644_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1096\/fj.05-4497fje","volume":"20","author":"MG Chelu","year":"2006","unstructured":"Chelu, M. G. et al. Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse. FASEB J. 20, 329\u2013330 (2006).","journal-title":"FASEB J."},{"key":"24644_CR34","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1096\/fj.11-197582","volume":"26","author":"B Yuen","year":"2012","unstructured":"Yuen, B. et al. Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage. FASEB J. 26, 1311\u20131322 (2012).","journal-title":"FASEB J."},{"key":"24644_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0378-5173(91)90193-R","volume":"75","author":"ACA Jansen","year":"1991","unstructured":"Jansen, A. C. A., Hilbers, H. W., Ni, X. R., Helden, S. P.van & Janssen, L. H. M. Some physical-chemical properties of dantrolene and two of its analogues. Int. J. Pharm. 75, 193\u2013199 (1991).","journal-title":"Int. J. Pharm."},{"key":"24644_CR36","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/00000542-199205000-00008","volume":"76","author":"JR Lopez","year":"1992","unstructured":"Lopez, J. R., Gerardi, A., Lopez, M. J. & Allen, P. D. Effects of dantrolene on myoplasmic free [Ca2+] measured in vivo in patients susceptible to malignant hyperthermia. Anesthesiology 76, 711\u2013719 (1992).","journal-title":"Anesthesiology"},{"key":"24644_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/bja\/aer132","volume":"107","author":"PM Hopkins","year":"2011","unstructured":"Hopkins, P. M. Malignant hyperthermia: pharmacology of triggering. Br. J. Anaesth. 107, 48\u201356 (2011).","journal-title":"Br. J. Anaesth."},{"key":"24644_CR38","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1096\/fj.12-218354","volume":"27","author":"JM Eltit","year":"2013","unstructured":"Eltit, J. M., Ding, X., Pessah, I. N., Allen, P. D. & Lopez, J. R. Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia. FASEB J. 27, 991\u20131000 (2013).","journal-title":"FASEB J."},{"key":"24644_CR39","doi-asserted-by":"publisher","first-page":"e77633","DOI":"10.1371\/journal.pone.0077633","volume":"8","author":"V Yarotskyy","year":"2013","unstructured":"Yarotskyy, V., Protasi, F. & Dirksen, R. T. Accelerated activation of SOCE current in myotubes from two mouse models of anesthetic- and heat-induced sudden death. PLoS One 8, e77633 (2013).","journal-title":"PLoS One"},{"key":"24644_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1213\/00000539-198910000-00015","volume":"69","author":"MG Larach","year":"1989","unstructured":"Larach, M. G. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group. Anesth. Analg. 69, 511\u2013515 (1989).","journal-title":"Anesth. Analg."},{"key":"24644_CR41","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1476-5381.1981.tb09147.x","volume":"72","author":"GC Leslie","year":"1981","unstructured":"Leslie, G. C. & Part, N. J. The action of dantrolene sodium on rat fast and slow muscle in vivo. Br. J. Pharm. 72, 665\u2013672 (1981).","journal-title":"Br. J. Pharm."},{"key":"24644_CR42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0014-2999(79)90457-6","volume":"53","author":"WJ Meyler","year":"1979","unstructured":"Meyler, W. J., Mols-Thurkow, I., Scaf, A. H., Sargo, S. & Wesseling, H. The effect of dantrolene sodium on rat skeletal muscle in relation to the plasma concentration. Eur. J. Pharm. 53, 335\u2013342 (1979).","journal-title":"Eur. J. Pharm."},{"key":"24644_CR43","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/EJA.0b013e3283439545","volume":"28","author":"JK Schutte","year":"2011","unstructured":"Schutte, J. K. et al. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs. Eur. J. Anaesthesiol. 28, 256\u2013264 (2011).","journal-title":"Eur. J. Anaesthesiol."},{"key":"24644_CR44","first-page":"PD01","volume":"11","author":"AK Sinha","year":"2017","unstructured":"Sinha, A. K., Kumari, P., Vaghela, M. M., Sinha, C. & Kumar, B. Postoperative malignant hyperthermia- a medical emergency: a case report and review of literature. J. Clin. Diagn. Res. 11, PD01\u2013PD02 (2017).","journal-title":"J. Clin. Diagn. Res."},{"key":"24644_CR45","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/00000542-198904000-00013","volume":"70","author":"J Lerman","year":"1989","unstructured":"Lerman, J., McLeod, M. E. & Strong, H. A. Pharmacokinetics of intravenous dantrolene in children. Anesthesiology 70, 625\u2013629 (1989).","journal-title":"Anesthesiology"},{"key":"24644_CR46","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/cc2923","volume":"9","author":"E Hadad","year":"2005","unstructured":"Hadad, E., Cohen-Sivan, Y., Heled, Y. & Epstein, Y. Clinical review: treatment of heat stroke: should dantrolene be considered? Crit. Care 9, 86\u201391 (2005).","journal-title":"Crit. Care"},{"key":"24644_CR47","unstructured":"Simon L. V., Hashmi M. F. & Callahan A. L. Neuroleptic Malignant Syndrome. (In: StatPearls) (2020)."},{"key":"24644_CR48","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s13181-011-0162-6","volume":"7","author":"J Grundlingh","year":"2011","unstructured":"Grundlingh, J., Dargan, P. I., El-Zanfaly, M. & Wood, D. M. 2,4-dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death. J. Med. Toxicol. 7, 205\u2013212 (2011).","journal-title":"J. Med. Toxicol."},{"key":"24644_CR49","doi-asserted-by":"publisher","first-page":"e13250","DOI":"10.14814\/phy2.13250","volume":"5","author":"H Eshima","year":"2017","unstructured":"Eshima, H. et al. Long-term, but not short-term high-fat diet induces fiber composition changes and impaired contractile force in mouse fast-twitch skeletal muscle. Physiol. Rep. 5, e13250 (2017).","journal-title":"Physiol. Rep."},{"key":"24644_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-3495(83)84316-1","volume":"43","author":"JR Lopez","year":"1983","unstructured":"Lopez, J. R., Alamo, L., Caputo, C., DiPolo, R. & Vergara, S. Determination of ionic calcium in frog skeletal muscle fibers. Biophys. J. 43, 1\u20134 (1983).","journal-title":"Biophys. J."},{"key":"24644_CR51","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.expneurol.2004.06.029","volume":"190","author":"KD Anderson","year":"2004","unstructured":"Anderson, K. D., Abdul, M. & Steward, O. Quantitative assessment of deficits and recovery of forelimb motor function after cervical spinal cord injury in mice. Exp. Neurol. 190, 184\u2013191 (2004).","journal-title":"Exp. Neurol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24644-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24644-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24644-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T13:25:45Z","timestamp":1669987545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24644-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["24644"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-24644-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,13]]},"assertion":[{"value":"10 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4293"}}